XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 25, 2022   111,132,993    
Beginning balance at Dec. 25, 2022 $ 541,226,000 $ 111,000 $ 1,212,716,000 $ (671,601,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (60,915,000)     (60,915,000)
Exercise of stock options (in shares) 521,242 521,242    
Exercise of stock options $ 2,510,000 $ 1,000 2,509,000  
Issuance of common stock related to restricted shares (in shares)   298,778    
Shares repurchased for employee tax withholding (in shares)   6,559    
Shares repurchased for employee tax withholding (164,000)   (164,000)  
Stock-based compensation expense 28,667,000   28,667,000  
Ending balance (in shares) at Jun. 25, 2023   111,946,454    
Ending balance at Jun. 25, 2023 511,324,000 $ 112,000 1,243,728,000 (732,516,000)
Beginning balance (in shares) at Mar. 26, 2023   111,443,502    
Beginning balance at Mar. 26, 2023 522,557,000 $ 111,000 1,227,704,000 (705,258,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (27,258,000)     (27,258,000)
Exercise of stock options (in shares)   360,278    
Exercise of stock options $ 1,743,000 $ 1,000 1,742,000  
Issuance of common stock related to restricted shares (in shares)   143,220    
Shares repurchased for employee tax withholding (in shares) (546)      
Shares repurchased for employee tax withholding $ (120,000)      
Stock-based compensation expense 14,402,000   14,402,000  
Ending balance (in shares) at Jun. 25, 2023   111,946,454    
Ending balance at Jun. 25, 2023 511,324,000 $ 112,000 1,243,728,000 (732,516,000)
Beginning balance (in shares) at Dec. 31, 2023   112,639,146    
Beginning balance at Dec. 31, 2023 482,597,000 $ 113,000 1,267,469,000 (784,985,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (40,527,000)     (40,527,000)
Exercise of stock options (in shares) 1,028,184 1,028,184    
Exercise of stock options $ 5,404,000 $ 1,000 5,403,000  
Issuance of common stock related to Spyce milestone achievement (in shares)   208,042    
Issuance of common stock related to Spyce milestone achievement $ 2,132,000      
Issuance of common stock related to restricted shares (in shares)   264,346    
Shares repurchased for employee tax withholding (in shares) (186)      
Stock-based compensation expense $ 20,529,000   20,529,000  
Ending balance (in shares) at Jun. 30, 2024   114,139,532    
Ending balance at Jun. 30, 2024 470,135,000 $ 114,000 1,295,533,000 (825,512,000)
Beginning balance (in shares) at Mar. 31, 2024   113,209,760    
Beginning balance at Mar. 31, 2024 470,278,000 $ 113,000 1,281,217,000 (811,052,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (14,460,000)     (14,460,000)
Exercise of stock options (in shares)   770,983    
Exercise of stock options $ 3,414,000 $ 1,000 3,413,000  
Shares repurchased for employee tax withholding (in shares) (186) 158,975    
Stock-based compensation expense $ 10,903,000   10,903,000  
Ending balance (in shares) at Jun. 30, 2024   114,139,532    
Ending balance at Jun. 30, 2024 $ 470,135,000 $ 114,000 $ 1,295,533,000 $ (825,512,000)